We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluation of Impacts of Access to Credit and Loan Size for Microcredit Clients in South Africa

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00700349
Recruitment Status : Completed
First Posted : June 18, 2008
Last Update Posted : June 18, 2008
Sponsor:
Collaborators:
Information provided by:

Study Description
Brief Summary:
This study involves randomization of individuals who were initially rejected from a micro-lending organization in South Africa. Subjects were placed into two arms: (1) not receiving a loan; (2) being reconsidered for a "second look." Of those in the second arm, 53% were then selected by the organization's loan officers to receive a standard loan for first-time borrowers. Mental health and financial data were collected at one timepoint: approximately 6-12 months after the subjects first applied for the loan.

Condition or disease Intervention/treatment
Mental Health Depression Stress Other: Small loan

Study Design

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 3000 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single (Outcomes Assessor)
Official Title: Evaluation of Impacts of Access to Credit and Loan Size for Microcredit Clients in South Africa
Study Start Date : September 2004
Primary Completion Date : November 2005
Study Completion Date : November 2005
Arms and Interventions

Arm Intervention/treatment
No Intervention: 1
Individuals who were rejected from receiving a loan from a micro-lending organization were randomized to continue receiving no loan.
Experimental: 2
Individuals who were rejected from receiving a loan from a micro-lending organization were randomized to receive a "second look," to be reconsidered for a loan by loan officers.
Other: Small loan
Applicants in the treatment group were offered an interest rate, loan size, and maturity per the lender's standard underwriting criteria, involving a 4-month maturity at 11.75% per month, charged on the original balance (200% annual percentage rate).


Outcome Measures

Primary Outcome Measures :
  1. Center for Epidemiologic Studies Depression Scale (CES-D), a 20-item questionnaire (0 = no risk, 60 = highest risk) [ Time Frame: At follow-up (6-12 months after subject enrollment) ]
  2. Perceived stress, measured using the Cohen's Perceived Stress Scale (PSS), a 10-item questionnaire (0 = no stress, 40 = high stress) [ Time Frame: At follow-up (6-12 months after subject enrollment) ]

Secondary Outcome Measures :
  1. Household income, measured by a variety of questions that asked about all sources of income obtained by all members of the applicant's household. [ Time Frame: At follow-up (6-12 months after subject enrollment) ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Subjects were recruited from those who had been rejected from a lending organization for non-fraudulent or non-overindebtness reasons.

Exclusion Criteria:

Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00700349


Locations
South Africa
Innovations for Poverty Action
Cape Town, South Africa
Innovations for Poverty Action
Durban, South Africa
Innovations for Poverty Action
Port Elizabeth, South Africa
Sponsors and Collaborators
Innovations for Poverty Action
Broadening Access and Strengthening Input Market Systems/USAID
U.S. National Science Foundation
Bill and Melinda Gates Foundation
Princeton University
Social Science Research Council Program in Applied Economics
Federal Reserve Bank of New York
Investigators
Principal Investigator: Dean Karlan, PhD Innovations for Poverty Action
Principal Investigator: Jonathan Zinman, PhD Dartmouth University
Principal Investigator: Lia Fernald, PhD University of California, Berkeley
More Information

Responsible Party: Dean Karlan, Innovations for Poverty Action
ClinicalTrials.gov Identifier: NCT00700349     History of Changes
Other Study ID Numbers: IPA-2004-SA
First Posted: June 18, 2008    Key Record Dates
Last Update Posted: June 18, 2008
Last Verified: June 2008

Keywords provided by Innovations for Poverty Action:
depression
stress
microcredit
poverty
South Africa

Additional relevant MeSH terms:
Depression
Behavioral Symptoms